Contract award · W81XWH22C0040
R&D DHA PHASE II SBIR MONTHS 1-23 FOR PROJECT TITLED, "NOVEL BIOLOGIC COUNTERMEASURE FOR ACUTE RADIATION SYNDROME".
Awarded to TECHNOLOGY HOLDING, LLC · CAGE 5CTM1
Latest reported total obligated
Not reported
Net observed obligations
$3M
Observed contract actions
0
Observed period
Not available
Reported totals are cumulative values from the latest available award record. Observed obligations and actions reflect Mimir's FY2019 onward transaction window and may omit earlier activity.
Award parties and scope
ContractorTECHNOLOGY HOLDING, LLC
CAGE5CTM1
CustomerDefense Health Agency
Performance locationWEST VALLEY CITY, UTAH, UNITED STATES
PlatformHealthcareProcurement details
First observed actionJun 17, 2022
Latest observed actionAug 12, 2025
PSCAN11
NAICS541715
CompetitionFULL AND OPEN COMPETITION AFTER EXCLUSION OF SOURCES
PricingFIRM FIXED PRICE
SolicitationHQ003420R2ADB
Continue exploring
Ask Mimir about W81XWH22C0040
Continue with this contract award already in context.
ContinueExplore the full award in Mimir
Open the complete action history and connected analysis in the platform.